Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Commissioning and performance evaluation of RadCalc for the Elekta unity MRI-linac.

Graves SA, Snyder JE, Boczkowski A, St-Aubin J, Wang D, Yaddanapudi S, Hyer DE.

J Appl Clin Med Phys. 2019 Dec;20(12):54-62. doi: 10.1002/acm2.12760. Epub 2019 Nov 13.

2.

Dose point kernels for 2,174 radionuclides.

Graves SA, Flynn RT, Hyer DE.

Med Phys. 2019 Nov;46(11):5284-5293. doi: 10.1002/mp.13789. Epub 2019 Sep 18.

PMID:
31461537
3.

In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem.

Shi S, Chen F, Goel S, Graves SA, Luo H, Theuer CP, Engle JW, Cai W.

Nanomicro Lett. 2018;10(4):65. doi: 10.1007/s40820-018-0216-2. Epub 2018 Jul 16.

4.

Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin.

Graves SA, Kutyreff C, Barrett KE, Hernandez R, Ellison PA, Happel S, Aluicio-Sarduy E, Barnhart TE, Nickles RJ, Engle JW.

Nucl Med Biol. 2018 Sep - Oct;64-65:1-7. doi: 10.1016/j.nucmedbio.2018.06.003. Epub 2018 Jun 18.

5.

Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging.

Zhan Y, Ehlerding EB, Shi S, Graves SA, Goel S, Engle JW, Liang J, Cai W.

J Biomed Nanotechnol. 2018 May 1;14(5):900-909. doi: 10.1166/jbn.2018.2498.

6.

Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.

Zhan Y, Shi S, Ehlerding EB, Graves SA, Goel S, Engle JW, Liang J, Tian J, Cai W.

ACS Appl Mater Interfaces. 2017 Nov 8;9(44):38304-38312. doi: 10.1021/acsami.7b12216. Epub 2017 Oct 24.

7.

Preparation and in vivo characterization of 51MnCl2 as PET tracer of Ca2+ channel-mediated transport.

Graves SA, Hernandez R, Valdovinos HF, Ellison PA, Engle JW, Barnhart TE, Cai W, Nickles RJ.

Sci Rep. 2017 Jun 8;7(1):3033. doi: 10.1038/s41598-017-03202-0.

8.

CD38 as a PET Imaging Target in Lung Cancer.

Ehlerding EB, England CG, Jiang D, Graves SA, Kang L, Lacognata S, Barnhart TE, Cai W.

Mol Pharm. 2017 Jul 3;14(7):2400-2406. doi: 10.1021/acs.molpharmaceut.7b00298. Epub 2017 Jun 8.

9.

Radiomanganese PET Detects Changes in Functional β-Cell Mass in Mouse Models of Diabetes.

Hernandez R, Graves SA, Gregg T, VanDeusen HR, Fenske RJ, Wienkes HN, England CG, Valdovinos HF, Jeffery JJ, Barnhart TE, Severin GW, Nickles RJ, Kimple ME, Merrins MJ, Cai W.

Diabetes. 2017 Aug;66(8):2163-2174. doi: 10.2337/db16-1285. Epub 2017 May 17.

10.

ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.

Luo H, England CG, Goel S, Graves SA, Ai F, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W.

Mol Pharm. 2017 May 1;14(5):1646-1655. doi: 10.1021/acs.molpharmaceut.6b01123. Epub 2017 Mar 24.

11.

Nuclear excitation functions of proton-induced reactions (Ep = 35 - 90 MeV) from Fe, Cu, and Al.

Graves SA, Ellison PA, Barnhart TE, Valdovinos HF, Birnbaum ER, Nortier FM, Nickles RJ, Engle JW.

Nucl Instrum Methods Phys Res B. 2016 Nov 1;386:44-53. doi: 10.1016/j.nimb.2016.09.018. Epub 2016 Sep 28.

12.

Optimized procedures for manganese-52: Production, separation and radiolabeling.

Fonslet J, Tietze S, Jensen AI, Graves SA, Severin GW.

Appl Radiat Isot. 2017 Mar;121:38-43. doi: 10.1016/j.apradiso.2016.11.021. Epub 2016 Dec 21.

PMID:
28024217
13.

Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies.

Goel S, Chen F, Luan S, Valdovinos HF, Shi S, Graves SA, Ai F, Barnhart TE, Theuer CP, Cai W.

Adv Sci (Weinh). 2016 May 27;3(11):1600122. eCollection 2016 Nov.

14.

Spot-welding solid targets for high current cyclotron irradiation.

Ellison PA, Valdovinos HF, Graves SA, Barnhart TE, Nickles RJ.

Appl Radiat Isot. 2016 Dec;118:350-353. doi: 10.1016/j.apradiso.2016.10.010. Epub 2016 Oct 13.

15.

Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain.

Brunnquell CL, Hernandez R, Graves SA, Smit-Oistad I, Nickles RJ, Cai W, Meyerand ME, Suzuki M.

Contrast Media Mol Imaging. 2016 Sep;11(5):371-380. doi: 10.1002/cmmi.1701. Epub 2016 Jul 11.

16.

Development of a novel linearly-filled Derenzo microPET phantom.

Cox BL, Graves SA, Farhoud M, Barnhart TE, Jeffery JJ, Eliceiri KW, Nickles RJ.

Am J Nucl Med Mol Imaging. 2016 Jul 6;6(3):199-204. eCollection 2016.

17.

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.

England CG, Ehlerding EB, Hernandez R, Rekoske BT, Graves SA, Sun H, Liu G, McNeel DG, Barnhart TE, Cai W.

J Nucl Med. 2017 Jan;58(1):162-168. doi: 10.2967/jnumed.116.177857. Epub 2016 Aug 4.

18.

ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.

Sun H, England CG, Hernandez R, Graves SA, Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y, Cai W.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2169-2179. doi: 10.1007/s00259-016-3442-1. Epub 2016 Jun 25.

19.

Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.

Im HJ, England CG, Feng L, Graves SA, Hernandez R, Nickles RJ, Liu Z, Lee DS, Cho SY, Cai W.

ACS Appl Mater Interfaces. 2016 Jul 20;8(28):17955-63. doi: 10.1021/acsami.6b05840. Epub 2016 Jul 7.

20.

Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.

England CG, Im HJ, Feng L, Chen F, Graves SA, Hernandez R, Orbay H, Xu C, Cho SY, Nickles RJ, Liu Z, Lee DS, Cai W.

Biomaterials. 2016 Sep;100:101-9. doi: 10.1016/j.biomaterials.2016.05.018. Epub 2016 May 21.

21.

Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging.

Xu C, Shi S, Feng L, Chen F, Graves SA, Ehlerding EB, Goel S, Sun H, England CG, Nickles RJ, Liu Z, Wang T, Cai W.

Nanoscale. 2016 Jul 7;8(25):12683-92. doi: 10.1039/c5nr09193d. Epub 2016 Apr 25.

22.

Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles.

Chen F, Goel S, Hernandez R, Graves SA, Shi S, Nickles RJ, Cai W.

Small. 2016 May;12(20):2775-82. doi: 10.1002/smll.201600194. Epub 2016 Apr 9.

23.

Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.

Luo H, England CG, Shi S, Graves SA, Hernandez R, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W.

Clin Cancer Res. 2016 Aug 1;22(15):3821-30. doi: 10.1158/1078-0432.CCR-15-2054. Epub 2016 Mar 29.

24.

Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.

Yang Y, Hernandez R, Rao J, Yin L, Qu Y, Wu J, England CG, Graves SA, Lewis CM, Wang P, Meyerand ME, Nickles RJ, Bian XW, Cai W.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6525-34. doi: 10.1073/pnas.1502648112. Epub 2015 Nov 9.

25.

PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.

Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W.

J Nucl Med. 2016 Feb;57(2):285-90. doi: 10.2967/jnumed.115.166462. Epub 2015 Nov 5.

26.

A porphyrin-PEG polymer with rapid renal clearance.

Huang H, Hernandez R, Geng J, Sun H, Song W, Chen F, Graves SA, Nickles RJ, Cheng C, Cai W, Lovell JF.

Biomaterials. 2016 Jan;76:25-32. doi: 10.1016/j.biomaterials.2015.10.049. Epub 2015 Oct 21.

27.

Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry.

Luo H, Hernandez R, Hong H, Graves SA, Yang Y, England CG, Theuer CP, Nickles RJ, Cai W.

Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12806-11. doi: 10.1073/pnas.1509667112. Epub 2015 Sep 28.

28.

Novel Preparation Methods of (52)Mn for ImmunoPET Imaging.

Graves SA, Hernandez R, Fonslet J, England CG, Valdovinos HF, Ellison PA, Barnhart TE, Elema DR, Theuer CP, Cai W, Nickles RJ, Severin GW.

Bioconjug Chem. 2015 Oct 21;26(10):2118-24. doi: 10.1021/acs.bioconjchem.5b00414. Epub 2015 Sep 10.

29.

Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.

Hernandez R, Czerwinski A, Chakravarty R, Graves SA, Yang Y, England CG, Nickles RJ, Valenzuela F, Cai W.

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1859-68. doi: 10.1007/s00259-015-3085-7. Epub 2015 May 28.

30.

PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.

Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles RJ, Cai W.

J Nucl Med. 2015 Jun;56(6):927-32. doi: 10.2967/jnumed.114.153098. Epub 2015 Apr 16.

31.

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.

Chen F, Hong H, Goel S, Graves SA, Orbay H, Ehlerding EB, Shi S, Theuer CP, Nickles RJ, Cai W.

ACS Nano. 2015;9(4):3926-34. doi: 10.1021/nn507241v. Epub 2015 Apr 8.

32.

PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.

Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W.

J Nucl Med. 2015 May;56(5):758-63. doi: 10.2967/jnumed.115.154690. Epub 2015 Apr 3.

33.

ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment.

Shi S, Hong H, Orbay H, Graves SA, Yang Y, Ohman JD, Liu B, Nickles RJ, Wong HC, Cai W.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1295-303. doi: 10.1007/s00259-015-3038-1. Epub 2015 Mar 24.

34.

Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles.

Rieffel J, Chen F, Kim J, Chen G, Shao W, Shao S, Chitgupi U, Hernandez R, Graves SA, Nickles RJ, Prasad PN, Kim C, Cai W, Lovell JF.

Adv Mater. 2015 Mar 11;27(10):1785-90. doi: 10.1002/adma.201404739. Epub 2015 Jan 14.

35.

Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting.

Hong H, Wang F, Zhang Y, Graves SA, Eddine SB, Yang Y, Theuer CP, Nickles RJ, Wang X, Cai W.

ACS Appl Mater Interfaces. 2015 Feb 11;7(5):3373-81. doi: 10.1021/am508440j. Epub 2015 Jan 29.

36.

PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.

Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W.

Mol Pharm. 2015 Feb 2;12(2):403-10. doi: 10.1021/mp500766x. Epub 2015 Jan 20.

37.

⁵²Mn production for PET/MRI tracking of human stem cells expressing divalent metal transporter 1 (DMT1).

Lewis CM, Graves SA, Hernandez R, Valdovinos HF, Barnhart TE, Cai W, Meyerand ME, Nickles RJ, Suzuki M.

Theranostics. 2015 Jan 1;5(3):227-39. doi: 10.7150/thno.10185. eCollection 2015.

38.

Generation and screening of monoclonal antibodies for immunoPET imaging of IGF1R in prostate cancer.

Hong H, Nayak TR, Shi S, Graves SA, Fliss BC, Barnhart TE, Cai W.

Mol Pharm. 2014 Oct 6;11(10):3624-30. doi: 10.1021/mp5003637. Epub 2014 Sep 4.

39.

A model for educational simulation of infant cardiovascular physiology.

Goodwin JA, van Meurs WL, Sá Couto CD, Beneken JE, Graves SA.

Anesth Analg. 2004 Dec;99(6):1655-64, table of contents.

PMID:
15562049
40.

Recommended guidelines for uniform reporting of data from drowning: the "Utstein style".

Idris AH, Berg RA, Bierens J, Bossaert L, Branche CM, Gabrielli A, Graves SA, Handley AJ, Hoelle R, Morley PT, Papa L, Pepe PE, Quan L, Szpilman D, Wigginton JG, Modell JH; American Heart Association.

Circulation. 2003 Nov 18;108(20):2565-74. Review. No abstract available.

PMID:
14623794
41.

Recommended guidelines for uniform reporting of data from drowning: the "Utstein style".

Idris AH, Berg RA, Bierens J, Bossaert L, Branche CM, Gabrielli A, Graves SA, Handley AJ, Hoelle R, Morley PT, Papa L, Pepe PE, Quan L, Szpilman D, Wigginton JG, Modell JH; American Heart Association; Maatschappij tot Redding van Drenkelingen; European Resuscitation Council; US Centers for Disease Control and Prevention; University of Florida; University of North Carolina; Australia and New Zealand Resuscitation Council; InterAmerican Heart Foundation; Heart and Stroke Foundation of Canada; Resuscitation Council of Southern Africa.

Resuscitation. 2003 Oct;59(1):45-57. Review. No abstract available.

PMID:
14580734
43.

[A long-term study of the visual fields in patients treated with betaxolol and timolol].

Flammer J, Collignon-Brach J, Demailly P, Graves SA.

Oftalmologia. 1998;42(1):77-82; discussion 82-3. Romanian. No abstract available.

PMID:
9713206
44.

Intramuscular atropine sulfate in children: comparison of injection sites.

Sullivan KJ, Berman LS, Koska J, Goodwin SR, Setzer N, White SE, Graves SA, Nall AV.

Anesth Analg. 1997 Jan;84(1):54-8.

PMID:
8988999
45.

Pulse oximetry monitoring can change routine oxygen supplementation practices in the postanesthesia care unit.

DiBenedetto RJ, Graves SA, Gravenstein N, Konicek C.

Anesth Analg. 1994 Feb;78(2):365-8.

PMID:
8311292
46.

Pediatric considerations in a general postanesthesia care unit.

Wilson TA, Graves SA.

J Post Anesth Nurs. 1990 Feb;5(1):16-24. No abstract available.

PMID:
1693959
47.

Umbilical catheters and arterial blood pressure monitoring.

Goodwin SR, Graves SA, van der Aa J.

J Clin Monit. 1985 Oct;1(4):227-31.

PMID:
3831265
48.

Total lung lavage for pulmonary alveolar proteinosis in an infant without the use of cardiopulmonary bypass.

Moazam F, Schmidt JH, Chesrown SE, Graves SA, Sauder RA, Drummond J, Heard SO, Talbert JL.

J Pediatr Surg. 1985 Aug;20(4):398-401.

PMID:
4045665
49.

Catheters for arterial pressure monitoring in pediatrics.

Fiser DH, Graves SA, van der Aa J.

Crit Care Med. 1985 Jul;13(7):580-3.

PMID:
4006499
50.

Prolonged use of high-frequency jet ventilation for a pediatric patient.

Tilden SJ, Berman LS, Banner MJ, Graves SA.

Crit Care Med. 1985 Jun;13(6):508-9.

PMID:
3996006

Supplemental Content

Loading ...
Support Center